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Preclinical studies have suggested that increased adult neurogenesis in the hippocampus might have potential therapeutic effects for 
Alzheimer’s disease and depression; therefore, it is a target for the treatment of some brain diseases. In this technical communication, 
we propose a cell‑based fluorescence assay to study the neurogenesis of adult hippocampal progenitor cells that can be used for 
high‑throughput screening of drugs promoting neurogenesis. Three fluorescent dyes (DAPI, Alexa Fluor 488, and Alexa Fluor 594) and 
a fluorescence spectrophotometry reader were used, which confirmed that the mutual interference of the three fluorescent dyes is 
very low. We used this cell‑based fluorescence assay to evaluate the effects of three neurotrophic factors, ciliary neurotrophic factor 
(CNTF), insulin‑like growth factor 1 (IGF‑1), and IGF‑2 on the promotion of neurogenesis in adult hippocampal neural progenitor cells. 
The fluorescence intensity ratio of the neuronal marker, class III β‑tubulin, to the housekeeping protein, glyceraldehyde 3‑phosphate 
dehydrogenase, or nuclear staining dye, DAPI, in CNTF‑treated cells was significantly higher than in control cells. The ratios in IGF‑1‑ and 
IGF‑2‑treated cells were slightly higher under higher cell density conditions. These results are consistent with those in previous reports; 
therefore, this report proved the efficacy of this method. Taken together, the results showed that this simple, rapid, and economical 
cell‑based immunofluorescence assay could be a powerful tool for the rapid screening of drugs that promote adult neurogenesis.
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Substantial neurogenesis and continuous supple‑
mentation of newborn neurons in the hippocampus 
and striatum of human adults indicate that neurogene‑
sis may have important implications for brain function 
(Bergmann et al., 2015; Boldrini et al., 2018). Adult neu‑
rogenesis in the hippocampus is important for memory 
coding and mood regulation. Furthermore, alterations 
in adult neurogenesis are associated with several brain 
diseases, such as neurodegenerative diseases, ischemic 
stroke, and psychiatric disorders. Some symptoms of 
these diseases can be explained by the dysregulation 
of adult neurogenesis (Winner and Winkler, 2015; Toda 
et al., 2019). Preclinical studies have suggested that 
increased adult neurogenesis in the hippocampus has 
potential therapeutic benefits in patients with Alzhei‑
mer’s disease and depression (Iqbal and Grundke‑Iqbal, 
2011; Miller and Hen, 2015; Han et al., 2016). This has 
led to adult neurogenesis as a target for the treatment 
of some brain diseases.
Several methods can be used to detect neurogene‑
sis, including in vivo and in vitro labeling with the thy‑
midine analogue, bromodeoxyuridine (BrdU), endog‑
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enous cell‑cycle markers, and cell stage and lineage 
commitment markers (Kuhn et al., 2016). Each meth‑
od has its own strengths and limitations; however, 
when several compounds require quick screening to 
determine whether they promote neurogenesis, these 
methods may be unsuitable as they require several re‑
agents and are time‑consuming. Therefore, we propose 
a cell‑based fluorescence assay to study neurogenesis 
in adult hippocampal progenitor cells. This method is 
advantageous because it uses 96‑well fluorescence plate 
readers, which enables a large amount of experimental 
data, and dozens of compounds, to be read simultane‑
ously. This method could be effective in the screening 
stages of drug development. In addition, this method is 
more economical than those previously described.
The fluorescent dyes used for the cell‑based fluores‑
cence assay were DAPI (blue), Alexa Fluor 488 (green), 
and Alexa Fluor 594 (red). The fluorescence spectro‑
photometry reader was the Cyto Fluor Multi‑Well Plate 
Reader, series 4000 (PerSeptive Biosystems, MA, USA) 
with standard filter sets of the instrument used. The 
center wavelength/full bandwidth of excitation filter 
and emission filter for DAPI are 360/40 and 460/40; for 
Alexa Fluor 488 are 485/20 and 530/25; for Alexa Flu‑
or 594 are 590/20 and 645/40, respectively. The online 
tool, Fluorescence Spectra Viewer (https: //www.ther‑
mofisher.com/us/en/home/life‑science/cell‑analysis/
labeling‑chemistry/fluorescence‑spectraviewer.html), 
showed that there was almost no mutual interference 
under these conditions. 
To further confirm this result experimentally, we 
compared the fluorescence intensity (FI) values of sin‑
gle fluorescent dyes and the combination of the three 
fluorescent dyes. The fluorescent dyes were diluted in 
0.05 M Tris‑buffered saline (TBS, 50 mM Tris‑Cl, 150 mM 
NaCl, pH 7.6) at three dilutions (1, 1/3, and 1/9). The 
concentrations of DAPI (Thermo Fisher Scientific, 
Waltham, MA, USA) were 50, 16.7, and 5.6 µg/ml. The 
concentrations of Alexa Fluor 488‑conjugated goat an‑
ti‑rabbit (Alexa488) or Alexa Fluor 594‑conjugated goat 
anti‑mice (Alexa594) antibodies (Thermo Fisher Scien‑
tific) were 2.0, 0.67, and 0.22 µg/ml. In total, 100 μl of 
each sample was added into the wells of a 96‑well fluo‑
rescence‑based assay microplate (Thermo Fisher Scien‑
tific). Three wells were used per sample. The plate was 
read on a fluorescent spectrophotometer. The results 
showed that for a single fluorescent dye sample, the FI 
value is very low if read at a non‑corresponding filter 
setting and the differences in FI value in the mixture of 
fluorescent dyes compared to a single fluorescent dye 
were less than 7%. Therefore, the experimental results 
are consistent with the analysis results from the Fluo‑
rescence Spectra Viewer; that is, the mutual interfer‑
ence of the three fluorescent dyes is very low (Tables 
I, II, and III). 
We used this cell‑based fluorescence assay to eval‑
uate the effects of three neurotrophic factors on pro‑
moting neurogenesis of adult hippocampal neural 
progenitor cells; ciliary neurotrophic factor (CNTF) 
significantly induced neuronal differentiation, while 
Table I. The OD value of single and mixed fluorescent dyes at filter set 360 nm/450 nm, gain at 30.
Fluorescent dyes OD value Mean The changes (%) compared to a single fluorescent dye Mean
DAPI (50 µg/ml) 1063 1057 1078 1066.0
DAPI (16.7 µg/ml) 489 499 501 496.3
DAPI (5.6 µg/ml) 179 184 182 181.7
Alexa488 (2.0 µg/µl) 1 1 1 1.0
Alexa488 (0.67 µg/µl) 1 1 1 1.0
Alexa488 (0.22 µg/µl) 1 1 1 1.0
Alexa594 (2.0 µg/µl) 1 1 1 1.0
Alexa594 (0.67 µg/µl) 1 1 1 1.0
Alexa594 (0.22 µg/µl) 1 1 1 1.0
DAPI (50 µg/ml), Alexa488 (2.0 µg/ml), 
Alexa594 (2.0 µg/ml) 1011 1009 999 1006.3 –5.6 –2.1
DAPI (16.7 g/ml), Alexa488 (0.67 µg/ml), 
Alexa594 (0.22 µg/ml) 485 487 482 484.7 –2.4
DAPI (5.6 µg/ml), Alexa488 (0.22 µg/ml), 
Alexa594 (0.22 µg/ml) 183 183 188 184.7 1.7
Cell‑based fluorescence assay for neurogenesis 305Acta Neurobiol Exp 2019, 79: 303–309
insulin‑like growth factors 1 (IGF‑1) and 2 (IGF‑2) had 
a mild effect. Class III β-tubulin (TUBB3) was used as 
a neuronal marker, and nestin was used as a specific 
marker for adult hippocampal neural progenitor cells 
(Fig. 1) (Chen et al., 2007). The housekeeping protein 
glyceraldehyde‑3‑phosphate dehydrogenase (GAPDH) 
was used as a “loading control” and DAPI was used to 
represent cell numbers. To culture adult hippocampal 
neural progenitor cells, three‑month‑old Wistar rats 
(Hebei Medical University Experimental Animal Cen‑
ter) were euthanized with a lethal dose of Nembutal 
that was administered intraperitoneally (200 mg/kg). 
This protocol was consistent with the recommenda‑
tions of the institutional guidelines for the care and use 
of laboratory animals from the Research Ethics Com‑
mittee of the Second Hospital of Hebei Medical Univer‑
sity. Next, the hippocampus was dissected and cut into 
small pieces in Hibernate A/2% B27/0.5 mM glutamine 
(Thermo Fisher Scientific) on ice, followed by digestion 
with 12 ml papain (2 mg/ml) (Worthington, Freehold, 
NJ, USA) in Hibernate A/B27 for 30 min at 30°C with 
shaking, and washed gently with 5 ml Hibernate A/2% 
B27 once. The tissue was briefly triturated in 2 ml of 
Hibernate A/2% B27 with a 1 ml pipette, allowed to set‑
tle for 1 – 2 min, then 2 ml of supernatant was collect‑
ed. This dissociation procedure was repeated 3 times. 
The resulting 6 ml of cell suspension was spread over 
a 4 ml density gradient medium containing OptiPrep™ 
Density Gradient Medium (7, 9.4, 11.7, 16.4%, 1 ml each, 
in Hibernate A/2% B27) (Sigma‑Aldrich, St. Louis, MO, 
USA). This was centrifuged at 800 g at room tempera‑
ture for 15 min. The upper 7‑ml layer of supernatant 
Table II. The OD value of single and mixed fluorescent dyes at filter set 485 nm/530 nm, gain at 50.
Fluorescent dyes OD value Mean The changes (%) compared to a single fluorescent dye Mean
DAPI (50 µg/ml) 2 1 2 2.0
DAPI (16.7 µg/ml) 2 1 1 1.0
DAPI (5.6 µg/ml) 0 2 1 1.0
Alexa488 (2.0 µg/µl) 702 710 679 697.0
Alexa488 (0.67 µg/µl) 238 241 233 237.0
Alexa488 (0.22 µg/µl) 80 83 77 80.0
Alexa594 (2.0 µg/µl) 0 0 0 0.0
Alexa594 (0.67 µg/µl) 0 0 0 0.0
Alexa594 (0.22 µg/µl) 0 1 2 1.0
DAPI (50 µg/ml), Alexa488 (2.0 µg/ml), 
Alexa594 (2.0 µg/ml) 710 704 696 703.0 0.9 2.4
DAPI (16.7 g/ml), Alexa488 (0.67 µg/ml), 
Alexa594 (0.22 µg/ml) 247 248 244 246.0 3.8
DAPI (5.6 µg/ml), Alexa488 (0.22 µg/ml), 
Alexa594 (0.22 µg/ml) 81 82 84 82.0 2.5
Fig. 1. Immunofluorescent staining for a cell‑specific marker. This figure shows immunofluorescence with anti‑nestin antibody markers for immature 
hippocampal neural progenitors; scale bar: 10 μm.
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was discarded. The remaining 3 ml of supernatant was 
collected and diluted in 5 ml of Hibernate A/2% B27 and 
centrifuged at 800 g for 5 min. The supernatant was dis‑
carded and the cell pellet was re‑suspended in 15 ml 
Neurobasal A/2% B27/0.5 mM glutamine. The cells were 
plated into a 100 mm Corning cell culture treated (TC) 
dish (Corning Incorporated Life Sciences, Tewksbury, 
MA, USA) pre‑coated with 0.01% Poly‑D‑lysine (Sig‑
ma‑Aldrich). This was incubated at 37°C with 5% CO2 
for 1 h. The plates were washed with warm Neurobas‑
al A/B27 medium twice. Next, cells were cultured with 
culture medium containing Neurobasal A/B27/0.5 mM 
glutamine/100 unit/ml penicillin, 100 g/ml streptomy‑
cin (Thermo Fisher Scientific), and 10 ng/ml fibroblast 
growth factor 2 (FGF‑2) (Thermo Fisher Scientific). The 
medium was changed every 2 days. FGF‑2 (10 ng/ml) 
was used for the first two weeks, followed by 20 ng/ml 
for further culture. The cells were passaged at conflu‑
ence by trituration with a 1 ml pipette. The third pas‑
sage was used for this study.
The cells were seeded into a 96‑well black poly‑
styrene microplate (clear flat bottom, matrix active 
group TC‑treated) (Corning Incorporated Life Sciences) 
pre‑coated with 0.01% Poly‑D‑lysine at different cell 
densities (1×, 2×, 4×, 8× 104 per well) in 64 µl of culture 
medium with 5 ng/ml FGF‑2. The cells were treated 
the following day with 136 µl of culture medium (with 
5 ng/ml FGF‑2) containing different growth factors, 
then cultured for 2 days. For the control cells, only the 
culture medium was used; for CNTF, IGF‑1, and IGF‑2 
treated cells, the final concentration of each neuro‑
trophic factor was 10 ng/ml; there were no cells in the 
blank wells. For each treatment condition, three wells 
of cells were used, and the experiment was repeated at 
least three times. 
After 2 days of treatment, the cells were fixed by 
replacing the growth medium with 100 μl of 4% form‑
aldehyde in Phosphate‑buffered saline (PBS, 128 mM 
NaCl, 2 mM KCl, 8 mM Na2HPO4, 2 mM KH2PO4, pH 7.2) 
for 20 min. The formaldehyde solution was removed 
and cells were washed 3 times with 200 μl of washing 
buffer (0.1% Triton X‑100 in 0.05 M TBS). Each washing 
step was performed for 5 min with gentle shaking. The 
washing buffer was removed, 100 μl of blocking buffer 
(4% normal goat serum, 0.1% Tween‑20 diluted in TBS) 
was added, and the plates were incubated for 30 min 
at room temperature. The blocking buffer was replaced 
with primary antibodies (polyclonal rabbit antibody 
against neuronal TUBB3 (1:1000 dilution) (BioLegend, 
San Diego, CA, USA) and 6C5 monoclonal mouse anti‑
body against GAPDH (1:500 dilution) (Thermo Fisher 
Scientific) diluted in the blocking buffer and incubat‑
ed for 45 min at 37°C. The primary antibody was re‑
moved and the cells were washed for 3 × 5 min with 
200 μl of washing buffer. The cells were then incubated 
in 50 μl blocking buffer containing Alexa 488-conju‑
gated goat anti‑mouse antibody (1:1000 dilution) and 
Alexa 594‑conjugated goat anti‑rabbit antibody (1:1000 
dilution) for 1 h at room temperature. The secondary 
antibodies were removed, and the cells were rinsed 
3 times for 5 min with 200 μl washing buffer and then 
2 × 5 minutes with 200 μl TBS. The rabbit or mouse IgG 
Table III. The OD value of single and mixed fluorescent dyes at filter set 590 nm/645 nm, gain at 50.
Fluorescent dyes OD value Mean The changes (%) compared  to a single fluorescent dye Mean
DAPI (50 µg/ml) 0 0 0 0.0
DAPI (16.7 µg/ml) 0 1 0 0.0
DAPI (5.6 µg/ml) 0 1 0 0.0
Alexa488 (2.0 µg/µl) 0 1 0 0.0
Alexa488 (0.67 µg/µl) 1 0 0 0.0
Alexa488 (0.22 µg/µl) 0 0 1 0.0
Alexa594 (2.0 µg/µl) 416 399 392 402.0
Alexa594 (0.67 µg/µl) 137 135 139 137.0
Alexa594 (0.22 µg/µl) 46 45 45 45.0
DAPI (50 µg/ml), Alexa488 (2.0 µg/ml), 
Alexa594 (2.0 µg/ml) 438 427 417 427.0 6.2 6.5
DAPI (16.7 g/ml), Alexa488 (0.67 µg/ml), 
Alexa594 (0.22 µg/ml) 146 148 145 146.0 6.6
DAPI (5.6 µg/ml), Alexa488 (0.22 µg/ml), 
Alexa594 (0.22 µg/ml) 48 48 49 48.0 6.7
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was used respectively as a negative control. The cells 
were incubated for 10 min at room temperature in 50 µl 
TBS containing 50 µg/ml DAPI. The DAPI solution was 
aspirated and the cells were rinsed 3 times for 5 min 
with 200 μl TBS. The 96-well plate was gently tapped 
onto paper towels to remove excess liquid from the 
wells and 100 μl TBS was added to each well. The tri‑
ple‑labeled fluorescence image of adult hippocampal 
progenitor cells is shown in Fig. 2. The FI value of three 
fluorescent dyes in each well was measured on the Cyto 
Fluor Multi‑Well Plate Reader, series 4000 with the cor‑
responding filter setting. 
The results showed that the FI ratio of TUBB3 to 
GAPDH (TUBB3/GAPDH) in CNTF‑treated cells was sig‑
nificantly higher than control cells under all cell den‑
sity conditions. The TUBB3/GAPDH ratio in IGF‑1 and 
IGF‑2‑treated cells was slightly increased under higher 
cell density conditions (4× and 8 × 104/well), although 
not significantly (Fig. 3A). This result is consistent with 
previous reports (Chen et al., 2007). The FI ratio of BIII 
to DAPI (BIII/DAPI) in CNTF‑treated cells was signifi‑
cantly higher than that of control cells under the cell 
density of 1 ×, 2 × and 4 × 104/well. The ratio values of 
BIII/DAPI in CNTF‑treated cells significantly decreased 
with the increase in cell density (Fig. 3B). For the FI 
ratio of GAPDH to DAPI (GAPDH/DAPI), there was no 
significant difference between treated cells, however, 
this ratio value decreased significantly with increased 
cell density (Fig. 3C). These results indicate that the 
CNTF‑induced significant increase in BIII expression 
in adult hippocampal neural progenitor cells can be 
detected regardless of whether GAPDH or DAPI is used 
Fig. 2. Triple‑labeled fluorescence image of adult hippocampal progenitor cells. This figure shows confocal immunocytochemical analysis of cells co‑labeled 
with BIII (red), GAPDH (green), and DAPI (blue); scale bar: 10 μm.
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as a reference. In the same way, our previous exper‑
iments have confirmed CNTF increased the astroglial 
(GFAP) level (Chen et al., 2007). However, GAPDH was 
better because it is less affected by cell density. Under 
conditions of high cell density, the growth space of the 
cells is limited, resulting in a decrease in the content of 
cytoplasmic components relative to the content of the 
nucleus; the proportion of the cytoplasm decrease re‑
sulted in a reduction of the absolute difference in drug 
action, with a nonsignificant statistical difference, 
which is responsible for the decrease in BIII/DAPI and 
GAPDH/DAPI as the cell density increases. Therefore, if 
DAPI is used as a reference, the cell density should be 
between 1× and 4 × 104/well.
The majority of in vitro studies focus on the embry‑
onic or neonatal rat/mouse neural progenitor cell cul‑
ture because adult neural progenitor cells are difficult 
to cultivate. However, it has been shown that adult and 
embryonic/newborn neural progenitor cells do not 
perform equally in many aspects such as electrophys‑
iology, development, regeneration, and pathological 
features (Urbán and Guillemot, 2014; Zhang and Jiao, 
2015). Thus, for certain age‑related diseases, such as 
Alzheimer’s disease and Parkinson’s disease, the ap‑
plication of embryonic/newborn neural progenitors is 
not suitable. To simulate the physiological conditions 
of neurodegenerative diseases, adult hippocampal pro‑
genitor cells should be used.
Both neurosphere and adherent culture systems can 
be used to culture neuronal progenitor cells (Sun et al., 
2011; Guo et al., 2012); however, adherent culture sys‑
tems may be better for this type of cell‑based fluores‑
cence assay using a microplate. During the cultivation of 
adherent neural progenitor cells, there are some critical 
points that are worthy of attention: cell culture plate 
and coating: based on our experience, Corning cell cul‑
ture treated (TC) dishes (100 mm) or flasks (75 cm2) are 
the most suitable. Freshly prepared 0.01% poly‑D‑lysine 
should be used, the culture dish or flask coated for 3–6 h 
at room temperature, and then washed with 10 ml steril‑
ized water 5 times. Further, altering the number of wash‑
ing steps is not conducive to progenitor cell growth. We 
used 2 mg/ml papain instead of trypsin to digest the iso‑
lated hippocampal tissue because papain is gentler and 
does not overly digest, which ensures a stable digestion 
and high cell viability. We further purified neurons us‑
ing OptiPrep density gradient centrifugation. Compared 
with traditional methods, such as simple centrifugation, 
cell straining, and centrifugation, OptiPrep density gra‑
dient centrifugation can effectively remove impurities, 
such as cell debris, oligodendrocytes, and microglia. The 
brain and hippocampal tissue were stored in pre‑chilled 
Hibernate‑A/B27 media instead of Hanks or PBS after 
dissection. The neuronal metabolism remains in prog‑
ress in an ice bath; therefore, the sugar‑free environment 
of Hanks’ liquid is not conducive. The Hibernate‑A/B27 
medium contains a variety of nutrients, such as glucose, 
inorganic salts, pyruvic acid, amino acids, and vitamins, 
which can be used to preserve cells and to maintain the 
activity of cells to the maximal extent. The first gener‑
ation of cell culture generally takes 3–4 weeks. At this 
stage, the cells are very sensitive. Except for changing 
Fig. 3. Fluorescence intensity ratio of the markers used for staining adult 
hippocampal progenitor cells at different densities. This figure shows: (A) 
BIII/GAPDH in IGF‑1 and IGF‑2 treated cells slightly increased under higher 
cell density conditions; however, this was not statistically significant. (B) 
BIII/DAPI ratios in CNTF‑treated cells significantly decreased with an 
increase in cell density. (C) GAPDH/DAPI significantly decreased with 
increased cell density. *p<0.05; **p<0.01; ***.
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medium, repeated observation is not conducive to cell 
growth. In addition, during the immunofluorescence 
staining, the microplate should be rinsed as gently as 
possible to avoid cell detachment from the microplate.
With the development of combinatorial chemis‑
try and diverse compound libraries, the pharmaceuti‑
cal industry and academia have used high‑throughput 
screening (HTS) technology to screen thousands of nov‑
el compounds. HTS analysis can be divided into two cat‑
egories, biochemical assays, which require clear targets 
for drug action, such as enzymatic activity, receptor‑li‑
gand binding, ion channels, and protein–protein inter‑
actions; and cell‑based assays, which are based on the 
actions of a drug on whole cells. Often a direct molecular 
target is not required; therefore, cell‑based assays have 
become more favorable in recent years (An and Tolliday, 
2010). Detection methods used in cell‑based HTS assays 
include electrochemical methods, such as electrochem‑
ical biosensors (Liu et al., 2014); optical detection meth‑
ods, such as colorimetric, luminescent, or fluorescent 
methods (e.g. MTT assay and cell‑based ELISA) (Zang 
et al., 2012; Kohl and Ascoli, 2017); and high‑through‑
put image analysis. This method uses high‑throughput 
fluorescence and confocal microscopes with advanced 
analysis software (Nierode et al., 2016).
Here, we described a simple, rapid cell‑based immu‑
nofluorescence assay for screening the potential of new 
drugs to promote neurogenesis of adult hippocampal 
neural progenitor cells. The reagents and instruments 
used in this method are inexpensive and easy to obtain, 
and this assay can be performed in a laboratory under 
general conditions. In addition, this method can use dif‑
ferent antibodies to simultaneously label two target pro‑
teins related to neuronal differentiation, such as double‑
cortin, MAP2, NeuN, neurofilaments (e.g. NF-L and NF-M), 
neurotransmitter synthesizing enzymes (e.g. GAD and 
TH), and synaptic proteins (e.g. PSD‑95, synaptophysin, 
and VAMP). The third marker is DAPI, which serves as 
a reference for the number of cells to reduce the variation 
caused by the number of cells in a culture well. Therefore, 
this method could be a powerful tool for the rapid screen‑
ing of drugs that promote adult neurogenesis.
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